NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 166 filers reported holding NOVAVAX INC in Q3 2018. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $1,316,000 | +30.9% | 700,000 | -6.7% | 0.54% | +14.6% |
Q2 2018 | $1,005,000 | -74.9% | 750,000 | +36.4% | 0.47% | -85.1% |
Q2 2016 | $3,999,000 | +40.0% | 550,000 | -0.6% | 3.17% | +28.6% |
Q1 2016 | $2,856,000 | +331.4% | 553,500 | +163.6% | 2.46% | +240.8% |
Q3 2013 | $662,000 | – | 210,000 | – | 0.72% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parametrica Management Ltd | 61,882 | $438,000 | 2.76% |
BB BIOTECH AG | 8,330,000 | $58,893,000 | 1.87% |
Cormorant Asset Management, LP | 1,600,000 | $11,312,000 | 1.81% |
HARVEY CAPITAL MANAGEMENT INC | 623,950 | $4,411,000 | 1.76% |
WILLIAM HARRIS INVESTORS INC | 488,666 | $3,455,000 | 0.98% |
Eventide Asset Management | 2,097,500 | $14,829,000 | 0.86% |
AWM Investment Company, Inc. | 400,000 | $2,828,000 | 0.55% |
NORTHPOINTE CAPITAL LLC | 507,344 | $3,587,000 | 0.47% |
Rock Springs Capital Management LP | 715,000 | $5,055,000 | 0.41% |
Opus Point Partners Management, LLC | 100,000 | $707,000 | 0.39% |